Attenuation of persistent experimental pancreatitis pain by a bradykinin B2 receptor antagonist

Pancreas

Volumn 39, Issue 8, 2010, Pages 1220-1225

  Chen, Qingmin ^a   Vera Portocarrero, Louis P ^a   Ossipov, Michael H ^a   Vardanyan, Marina ^a   Lai, Josephine ^a   Porreca, Frank ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

bradykinin receptor; bradykinin receptor antagonists; pancreatitis pain

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; DIBUTYLTIN DICHLORIDE; DYNORPHIN; DYNORPHIN ANTIBODY; ICATIBANT;

ABDOMINAL DISCOMFORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PAIN; PANCREATITIS; PANCREATITIS PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; SPINAL GANGLION; UPREGULATION;

ABDOMINAL PAIN; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRADYKININ; DYNORPHINS; GANGLIA, SPINAL; GENE EXPRESSION; IMMUNE SERA; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, SPINAL; MALE; ORGANOTIN COMPOUNDS; PAIN; PANCREAS; PANCREATITIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD;

EID: 78049275744     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181df1c90     Document Type: Article

References (43)

1. Andren-Sandberg A, Hoem D, Gislason H. Pain management in chronic pancreatitis. Eur J Gastroenterol Hepatol. 2002;14(9):957-970.
2. Bonica JJ, Loeser JD, Chapman CR, et al. Causalgia and other reflex sympathetic dystrophies. The Management of Pain. Philadelphia, PA: Lea & Febiger; 1990:220-243.
3. DiMagno EP. Toward understanding (and management) of painful chronic pancreatitis. Gastroenterology. 1999;116(5):1252-1257.
4. Gachago C, Draganov PV. Pain management in chronic pancreatitis. World J Gastroenterol. 2008;14(20):3137-3148.
5. Di Sebastiano P, Fink T, Weihe E, et al. Immune cell infiltration and growth-associated protein 43 expression correlate with pain in chronic pancreatitis. Gastroenterology. 1997;112(5):1648-1655.
6. Woolf CJ, Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci U S A. 1999;96(14):7723-7730.
7. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288(5472):1765-1769.
8. Di Sebastiano P, di Mola FF, Bockman DE, et al. Chronic pancreatitis: the perspective of pain generation by neuroimmune interaction. Gut. 2003;52(6):907-911.
9. Kanaka R, Schaible HG, Schmidt RF. Activation of fine articular afferent units by bradykinin. Brain Res. 1985;327(1-2):81-90.
10. Kumazawa T, Mizumura K, Minagawa M, et al. Sensitizing effects of bradykinin on the heat responses of the visceral nociceptor. J Neurophysiol. 1991;66(6):1819-1824.
11. Manning DC, Raja SN, Meyer RA, et al. Pain and hyperalgesia after intradermal injection of bradykinin in humans. Clin Pharmacol Ther. 1991;50(6):721-729.
12. Neugebauer V, Schaible HG, Schmidt RF. Sensitization of articular afferents to mechanical stimuli by bradykinin. Pflugers Arch. 1989;415(3):330-335.
13. Marceau F, Bachvarov DR. Kinin receptors. Clin Rev Allergy Immunol. 1998;16(4):385-401.
14. Barlas A, Okamoto H, Greenbaum LM. T-kininogenVthe major plasma kininogen in rat adjuvant arthritis. Biochem Biophys Res Commun. 1985;129(1):280-286.
15. Barlas A, Okamoto H, Greenbaum LM. Increased plasma level of T-kininogen in rats treated with Freund's adjuvant. Adv Exp Med Biol. 1986;198(pt A):61-68.
16. Bianchi G, Salvati P, Barlassina C, et al. The kidney in essential hypertension. Contrib Nephrol. 1985;49:173-178.
17. Tsurufuji S, Kumakura S. Role of bradykinin in exudative reactions of inflammation in rats. Dermatologica. 1989;179(suppl 1):64-67.
18. Ruud TE, Aasen AO, Kierulf P, et al. Studies on the plasma kallikrein-kinin system in peritoneal exudate and plasma during experimental acute pancreatitis in pigs. Scand J Gastroenterol. 1985;20(7):877-882.
19. Asano M, Hatori C, Inamura N, et al. Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on different in vivo animal models of inflammation. Br J Pharmacol. 1997;122(7):1436-1440.
20. Calixto JB, Cabrini DA, Ferreira J, et al. Kinins in pain and inflammation. Pain. 2000;87(1):1-5.
21. Dray A, Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 1993;16(3):99-104.
22. Perkins MN, Campbell E, Dray A. Antinociceptive activity of the bradykinin B1 and B2 receptor antagonists, des-Arg9, [Leu8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat. Pain. 1993;53(2):191-197.
23. Rupniak NM, Boyce S, Webb JK, et al. Effects of the bradykinin B1 receptor antagonist des-Arg9[Leu8]bradykinin and genetic disruption of the B2 receptor on nociception in rats and mice. Pain. 1997;71(1):89-97.
24. Bloechle C, Kusterer K, Kuehn RM, et al. Inhibition of bradykinin B2 receptor preserves microcirculation in experimental pancreatitis in rats. Am J Physiol. 1998;274(1 pt 1):G42-G51.
25. Griesbacher T, Lembeck F. Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis. Br J Pharmacol. 1992;107(2):356-360.
26. Griesbacher T, Tiran B, Lembeck F. Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, HOE 140. Br J Pharmacol. 1993;108(2):405-411.
27. Kanbe T, Naruse S, Kitagawa M, et al. Effects of a bradykinin receptor antagonist (HOE140) on taurocholate-induced acute pancreatitis in rats. Pancreas. 1996;13(3):283-288.
28. Sparmann G, Merkord J, Jaschke A, et al. Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride. Gastroenterology. 1997;112(5):1664-1672.
29. Vera-Portocarrero LP, Lu Y, Westlund KN. Nociception in persistent pancreatitis in rats: effects of morphine and neuropeptide alterations. Anesthesiology. 2003;98(2):474-484.
30. Vera-Portocarrero LP, Yie JX, Kowal J, et al. Descending facilitation from the rostral ventromedial medulla maintains visceral pain in rats with experimental pancreatitis. Gastroenterology. 2006;130(7): 2155-2164.
31. Winston JH, Toma H, Shenoy M, et al. Acute pancreatitis results in referred mechanical hypersensitivity and neuropeptide up-regulation that can be suppressed by the protein kinase inhibitor k252a. J Pain. 2003;4(6):329-337.
32. Juan H, Lembeck F. Proceedings: Influence of prostaglandin E1, indomethacin, calcium and potassium on the action of nociceptive substances. Naunyn Schmiedebergs Arch Pharmacol. 1974; 282(0)(suppl 282):R242.
33. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980;32(1):1-46.
34. Griesbacher T, Amann R, Sametz W, et al. The nonpeptide B2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception. Br J Pharmacol. 1998;124(6):1328-1334.
35. Chao J, Chao L. Biochemistry, regulation and potential function of kallistatin. Biol Chem Hoppe Seyler. 1995;376(12):705-713.
36. Griesbacher T, Rainer I, Tiran B, et al. Mechanism of kinin release during experimental acute pancreatitis in rats: evidence for pro- as well as anti-inflammatory roles of oedema formation. Br J Pharmacol. 2003;139(2):299-308.
37. Satake K, Rozmanith JS, Appert H, et al. Hemodynamic change and bradykinin levels in plasma and lymph during experimental acute pancreatitis in dogs. Ann Surg. 1973;178(5):659-662.
38. Satake K, Rozmanith JS, Appert HE, et al. Hypotension and release of kinin-forming enzyme into ascitic fluid exudate during experimental pancreatitis in dogs. Ann Surg. 1973;177(4):497-502.
39. Holzer-Petsche U. Blood pressure and gastric motor responses to bradykinin and hydrochloric acid injected into somatic or visceral tissues. Naunyn Schmiedebergs Arch Pharmacol. 1992;346(2): 219-225.
40. Houghton AK, Wang CC, Westlund KN. Do nociceptive signals from the pancreas travel in the dorsal column? Pain. 2001;89(2-3): 207-220.
41. Luo MC, Chen Q, Ossipov MH, et al. Spinal dynorphin and bradykinin receptors maintain inflammatory hyperalgesia. J Pain. 2008;9(12): 1096-1105.
42. Lai J, Luo MC, Chen Q, et al. Pronociceptive actions of dynorphin via bradykinin receptors. Neurosci Lett. 2008;437(3):175-179.
43. Lai J, Luo MC, Chen Q, et al. Dynorphin A activates bradykinin receptors to maintain neuropathic pain. Nat Neurosci. 2006;9(12): 1534-1540.